AllQuantitative Report
Argus•October 21, 2020
Argus•October 21, 2020LMAT: What does Argus have to say about LMAT?
Summary
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeActions
Download Full ReportRelated Reports
- Analyst Report: Boston Scientific CorporationApr 24, 2024 •
BSX
- The Argus Innovation Model PortfolioApr 23, 2024 •
GOOGL, AMAT, AAPL, ANET, CVX, ADI, AXON, URI, COST, V, LLY, SPGI, PANW, META, NVDA, SYK, BSX, ORCL, CBOE, PWR, MCK, NOW, ADBE, LYFT, SCHW, MCHP, ISRG, AMZN, ODFL, CRM
- EW: Lowering target price to $95.00Apr 17, 2024 •
EW
- MMSI: What does Argus have to say about MMSI?Apr 17, 2024 •
MMSI
- AORT: Lowering target price to $21.00Apr 17, 2024 •
AORT